Significant gastrointestinal side effects can lead to dehydration, which may affect kidney function
Patients with established cardiovascular disease should receive a pharmacological treatment intensification with an agent that has demonstrated benefit in cardiovascular safety studies: In patients with pre-existing atherosclerotic cardiovascular disease (ASCVD), a GLP-1 receptor agonist, or SGLT-2 inhibitor with characterized cardiovascular safety should be used
It has also been shown to reduce waist circumference, curb unhealthy cravings, and extend the patients sense of fullness after eating
On average, our bodies contain 2025 grams of L-carnitine, and we get between 100300 mg from our diet (not including supplements).[1] What Does Carnitine Do
Note: These figures are approximate and can differ based on various factors
These interrelationships constitute a major mechanism for the control of feeding behaviors